Given the effects of STING agonists in HFD-induced obese mice [41], it is plausible to hypothesize that DsbA-L may inhibit the cGAS-STING pathway in T cells, potentially suppressing the development and progression of diabetes. The gene discussed is CGAS; the disease is diabetes mellitus.